We have located links that may give you full text access.
Does Delayed Operation Increase Morbidity and Mortality? An Analysis of Emergency General Surgery Procedures.
Journal of Trauma and Acute Care Surgery 2024 May 2
BACKGROUND: Early operation is assumed to improve outcomes after emergency general surgery (EGS) procedures; however, few data exist to inform this opinion. We aimed to (1) characterize time-to-operation patterns among EGS procedures and (2) test the association between timing and patient outcomes. We hypothesize that patients receiving later operations are at greater risk for mortality and morbidity.
METHODS: We performed a retrospective cohort study of the ACS National Surgical Quality Improvement Program (ACS-NSQIP) data for adults ages 18-89 who underwent non-elective intra-abdominal operations (appendectomy, cholecystectomy, small bowel resection, lysis of adhesions, and colectomy) from 2015-2020. The primary outcome was 30-day postoperative mortality. Secondary outcomes were serious morbidity and all morbidity. Admission-to-operation timing was calculated and classified as early (≤ 48 hours) or late (> 48 hours). A multivariable logistic regression model adjusted risk estimates for age, comorbidities, frailty (mFI-5), and other confounders.
RESULTS: Of 269,959 patients (mean age 47.0 years; 48.0 % male, 61.6% white), 88.7% underwent early operation, ranging from 70.36% (lysis of adhesions) to 98.67% (appendectomy). Unadjusted 30-day mortality was higher for late versus early operation (6.73% vs. 1.96%; p < 0.0001). After risk-adjustment, late operation significantly increased risk for 30-day mortality (OR 1.545, 95% CI 1.451 - 1.644), serious morbidity (OR 1.464, 95% CI 1.416-1.514), and all morbidity (OR 1.468, 95% CI 1.417-1.520). This mortality risk persisted for all EGS procedures; risk of serious and any morbidity persisted for all procedures except cholecystectomy.
CONCLUSIONS: Late operation significantly increased risk for 30-day mortality, serious morbidity, and all morbidity across a variety of EGS procedures. We believe these findings will inform decisions regarding timing of EGS operations and allocation of surgical resources.
LEVEL OF EVIDENCE: Level III.
METHODS: We performed a retrospective cohort study of the ACS National Surgical Quality Improvement Program (ACS-NSQIP) data for adults ages 18-89 who underwent non-elective intra-abdominal operations (appendectomy, cholecystectomy, small bowel resection, lysis of adhesions, and colectomy) from 2015-2020. The primary outcome was 30-day postoperative mortality. Secondary outcomes were serious morbidity and all morbidity. Admission-to-operation timing was calculated and classified as early (≤ 48 hours) or late (> 48 hours). A multivariable logistic regression model adjusted risk estimates for age, comorbidities, frailty (mFI-5), and other confounders.
RESULTS: Of 269,959 patients (mean age 47.0 years; 48.0 % male, 61.6% white), 88.7% underwent early operation, ranging from 70.36% (lysis of adhesions) to 98.67% (appendectomy). Unadjusted 30-day mortality was higher for late versus early operation (6.73% vs. 1.96%; p < 0.0001). After risk-adjustment, late operation significantly increased risk for 30-day mortality (OR 1.545, 95% CI 1.451 - 1.644), serious morbidity (OR 1.464, 95% CI 1.416-1.514), and all morbidity (OR 1.468, 95% CI 1.417-1.520). This mortality risk persisted for all EGS procedures; risk of serious and any morbidity persisted for all procedures except cholecystectomy.
CONCLUSIONS: Late operation significantly increased risk for 30-day mortality, serious morbidity, and all morbidity across a variety of EGS procedures. We believe these findings will inform decisions regarding timing of EGS operations and allocation of surgical resources.
LEVEL OF EVIDENCE: Level III.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app